Long-Acting Injectable PrEP Acceptable Among Sexual & Gender Minorities

Willingness to use long-acting injectable PrEP (LAI PrEP) was high among sexual and gender minority (SGM)
individuals in the Southeastern US, although there were some differences based on demographics, according
to findings published in the Journal of the International AIDS Society. Jeb Jones, PhD, MPH, MS, and
colleagues surveyed 583 SGM individuals aged 15-34. Most participants (N=393) expressed willingness to
use LAI PrEP that provided protection against HIV for 3 months. In that group, most (N=320) preferred LAI
PrEP compared with a daily oral pill or no preference. Transgender and non-binary respondents reported a
greater willingness to use LAI PrEP, as did those who engaged in condomless anal sex in the preceding 6
months. Compared with non-Hispanic White participants, Hispanic participants were more likely—and non-Hispanic
Black participants were less likely—to use LAI PrEP. “Decreased willingness to use LAI PrEP among groups
who are disproportionately affected by the HIV epidemic could exacerbate existing disparities in HIV
incidence,” Dr. Jones and colleagues wrote. “LAI PrEP is an acceptable option among SGM populations in
the Southern United States, but strategies will be needed to ensure equitable implementation.